BAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's Lymphoma

PHASE2UnknownINTERVENTIONAL
Timeline

Start Date

January 31, 2002

Conditions
Lymphoma
Interventions
DRUG

ortataxel

Trial Locations (15)

10461

Albert Einstein Clinical Cancer Center, The Bronx

10595

New York Medical College, Valhalla

11030

North Shore University Hospital, Manhasset

11235

HemOnCare, P.C., Brooklyn

13210

State University of New York - Upstate Medical University, Syracuse

33140

Mount Sinai Comprehensive Cancer Center, Miami Beach

38120

West Clinic, Memphis

71101

Veterans Affairs Medical Center - Shreveport, Shreveport

98109

Seattle Cancer Care Alliance, Seattle

60637-1470

University of Chicago Cancer Research Center, Chicago

71130-3932

Louisiana State University Health Sciences Center - Shreveport, Shreveport

08903

Cancer Institute of New Jersey, New Brunswick

53226-3596

Medical College of Wisconsin, Milwaukee

T6G 1Z2

Cross Cancer Institute, Edmonton

V6Z 1Y6

St. Paul's Hospital - Vancouver, Vancouver

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Theradex

INDUSTRY